Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
Background/Aims: The expression of PRAME and its role in hepatocellular carcinoma (HCC) remain unknown. The aim of this study was to examine the functional role of PRAME in HCC development and exploring the molecular mechanism. Methods: We first detected PRAME expression in 96 human HCC tissue sampl...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-02-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/487353 |
id |
doaj-ca524ccdcd74472d920bf92acfc0b2e0 |
---|---|
record_format |
Article |
spelling |
doaj-ca524ccdcd74472d920bf92acfc0b2e02020-11-25T02:07:44ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-02-014531121113510.1159/000487353487353Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated PathwayHanzhang ZhuJingrui WangJunjie YinBei LuQijun YangYafeng WanChangku JiaBackground/Aims: The expression of PRAME and its role in hepatocellular carcinoma (HCC) remain unknown. The aim of this study was to examine the functional role of PRAME in HCC development and exploring the molecular mechanism. Methods: We first detected PRAME expression in 96 human HCC tissue samples and correlated with clinicopathological characteristics and prognosis of the patients. We then established stable HCC cell lines with PRAME overexpression and knockdown followed by functional analysis in vitro. Further, we examined the relationship between PRAME and p53 pathway in vitro by using Western blotting. Finally, PRAME expression was detected to evaluate its correlation with p-p53 and p53 pathway related apoptotic proteins in xenograft tumor mouse model using immunohistochemistry. Results: PRAME expression was significantly higher in HCC tissues than in adjacent non-tumor tissues and their expression was positively correlated with alpha fetoprotein levels and tumor size. In addition, PRAME expression was associated with AJCC stage and is a potential biomarker of poor prognosis regarding 5-year overall survival in HCC. In vitro studies, we found that PRAME expression was higher in HCC cell lines than in normal hepatic cell line. Inhibited cell proliferation and increased cell apoptosis was observed in PRAME knockdown HCC cells. Futher, increased cell apoptosis was correlated with the proportion of cells in G0/G1 stage, activated p53 mediated apoptosis, and increased cyclin p21 expression. Xenograft analysis in nude mice also found that PRAME knockdown inhibited tumorigenesis while PRAME overexpression had opposite effect. Conclusions: In HCC, PRAME serves as a potential biomarker for poor prognosis and novel therapeutic target in treating this cancer. PRAME is a potential biomarker of poor prognosis in HCC. PRAME surpresses HCC cell death in vitro and in vivo by regulating p53 apoptotic signaling and may serve as a potential therapeutic target in HCC.https://www.karger.com/Article/FullText/487353PrameHepatocellular carcinomaP53prognostic biomarkerProliferationApoptosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hanzhang Zhu Jingrui Wang Junjie Yin Bei Lu Qijun Yang Yafeng Wan Changku Jia |
spellingShingle |
Hanzhang Zhu Jingrui Wang Junjie Yin Bei Lu Qijun Yang Yafeng Wan Changku Jia Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway Cellular Physiology and Biochemistry Prame Hepatocellular carcinoma P53 prognostic biomarker Proliferation Apoptosis |
author_facet |
Hanzhang Zhu Jingrui Wang Junjie Yin Bei Lu Qijun Yang Yafeng Wan Changku Jia |
author_sort |
Hanzhang Zhu |
title |
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway |
title_short |
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway |
title_full |
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway |
title_fullStr |
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway |
title_full_unstemmed |
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway |
title_sort |
downregulation of prame suppresses proliferation and promotes apoptosis in hepatocellular carcinoma through the activation of p53 mediated pathway |
publisher |
Cell Physiol Biochem Press GmbH & Co KG |
series |
Cellular Physiology and Biochemistry |
issn |
1015-8987 1421-9778 |
publishDate |
2018-02-01 |
description |
Background/Aims: The expression of PRAME and its role in hepatocellular carcinoma (HCC) remain unknown. The aim of this study was to examine the functional role of PRAME in HCC development and exploring the molecular mechanism. Methods: We first detected PRAME expression in 96 human HCC tissue samples and correlated with clinicopathological characteristics and prognosis of the patients. We then established stable HCC cell lines with PRAME overexpression and knockdown followed by functional analysis in vitro. Further, we examined the relationship between PRAME and p53 pathway in vitro by using Western blotting. Finally, PRAME expression was detected to evaluate its correlation with p-p53 and p53 pathway related apoptotic proteins in xenograft tumor mouse model using immunohistochemistry. Results: PRAME expression was significantly higher in HCC tissues than in adjacent non-tumor tissues and their expression was positively correlated with alpha fetoprotein levels and tumor size. In addition, PRAME expression was associated with AJCC stage and is a potential biomarker of poor prognosis regarding 5-year overall survival in HCC. In vitro studies, we found that PRAME expression was higher in HCC cell lines than in normal hepatic cell line. Inhibited cell proliferation and increased cell apoptosis was observed in PRAME knockdown HCC cells. Futher, increased cell apoptosis was correlated with the proportion of cells in G0/G1 stage, activated p53 mediated apoptosis, and increased cyclin p21 expression. Xenograft analysis in nude mice also found that PRAME knockdown inhibited tumorigenesis while PRAME overexpression had opposite effect. Conclusions: In HCC, PRAME serves as a potential biomarker for poor prognosis and novel therapeutic target in treating this cancer. PRAME is a potential biomarker of poor prognosis in HCC. PRAME surpresses HCC cell death in vitro and in vivo by regulating p53 apoptotic signaling and may serve as a potential therapeutic target in HCC. |
topic |
Prame Hepatocellular carcinoma P53 prognostic biomarker Proliferation Apoptosis |
url |
https://www.karger.com/Article/FullText/487353 |
work_keys_str_mv |
AT hanzhangzhu downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT jingruiwang downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT junjieyin downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT beilu downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT qijunyang downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT yafengwan downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway AT changkujia downregulationofpramesuppressesproliferationandpromotesapoptosisinhepatocellularcarcinomathroughtheactivationofp53mediatedpathway |
_version_ |
1724929953888206848 |